PL1874336T3 - Sposób poprawy uczenia i pamięci u niemowląt obejmujący podawanie glikomakropeptydu kazeinowego - Google Patents

Sposób poprawy uczenia i pamięci u niemowląt obejmujący podawanie glikomakropeptydu kazeinowego

Info

Publication number
PL1874336T3
PL1874336T3 PL06740067.1T PL06740067T PL1874336T3 PL 1874336 T3 PL1874336 T3 PL 1874336T3 PL 06740067 T PL06740067 T PL 06740067T PL 1874336 T3 PL1874336 T3 PL 1874336T3
Authority
PL
Poland
Prior art keywords
infant
administering
memory
improving learning
casein glycomacropeptide
Prior art date
Application number
PL06740067.1T
Other languages
English (en)
Inventor
Robert J. Mcmahon
Bing Wang
Steven Charles Rumsey
Jennie Brand-Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36928632&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1874336(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL1874336T3 publication Critical patent/PL1874336T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06740067.1T 2005-04-29 2006-03-28 Sposób poprawy uczenia i pamięci u niemowląt obejmujący podawanie glikomakropeptydu kazeinowego PL1874336T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/118,790 US20060247153A1 (en) 2005-04-29 2005-04-29 Method of improving learning and memory in mammals

Publications (1)

Publication Number Publication Date
PL1874336T3 true PL1874336T3 (pl) 2016-11-30

Family

ID=36928632

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06740067.1T PL1874336T3 (pl) 2005-04-29 2006-03-28 Sposób poprawy uczenia i pamięci u niemowląt obejmujący podawanie glikomakropeptydu kazeinowego

Country Status (15)

Country Link
US (1) US20060247153A1 (pl)
EP (1) EP1874336B1 (pl)
KR (1) KR100988156B1 (pl)
CN (2) CN101287486A (pl)
BR (1) BRPI0609916A2 (pl)
CA (1) CA2606515C (pl)
ES (1) ES2576255T3 (pl)
HK (1) HK1222301A1 (pl)
MX (1) MX2007013270A (pl)
MY (1) MY162096A (pl)
NO (1) NO20075077L (pl)
PL (1) PL1874336T3 (pl)
RU (1) RU2396975C2 (pl)
TW (1) TWI400082B (pl)
WO (1) WO2006118719A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006251562B2 (en) 2005-05-23 2012-03-22 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
US20090137459A1 (en) * 2005-11-21 2009-05-28 Katry Inversiones, S.L. Food Product for Enteral or Oral Nutrition
EP1972346B1 (en) * 2005-11-30 2015-10-14 Vegenat, S.A. Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
EP2116139A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support brain health in the elderly
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2397038A1 (en) * 2010-06-21 2011-12-21 Abbott Laboratories Early programming of brain function through soy protein feeding
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
RU2620370C2 (ru) 2011-12-14 2017-05-25 Нестек С.А. Эмульгированный пищевой продукт, содержащий молочный белок
GB201205856D0 (en) * 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
RU2526126C2 (ru) * 2012-08-20 2014-08-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский государственный педагогический университет им. А.И. Герцена" Способ оптимизации интеллектуальной деятельности обучающихся
EP2900088B1 (en) * 2012-09-27 2016-11-30 DSM IP Assets B.V. Liquid concentrated vitamin e compositions
WO2014171813A1 (en) 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
JP6603658B2 (ja) 2013-07-19 2019-11-06 カーギル インコーポレイテッド 脂肪酸及び脂肪酸誘導体の製造のための微生物及び方法
CN103431051A (zh) * 2013-08-06 2013-12-11 东北农业大学 一种含唾液酸婴儿配方奶粉的干法制备方法
EP2880993A1 (en) * 2013-12-04 2015-06-10 Abbott Laboratories Method of achieving memory and learning improvement by the administration of sialic acid
AU2014363490A1 (en) * 2013-12-10 2016-06-02 Société des Produits Nestlé S.A. Nutrition, exercise and cognitive development
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
FR3027206B1 (fr) * 2014-10-21 2021-06-04 Univ Paris Descartes Procede de test d'un nourrisson et dispositif adapte pour mettre en oeuvre le procede de test
WO2016145628A1 (en) 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
CN118252257B (zh) * 2022-12-28 2025-11-28 内蒙古伊利实业集团股份有限公司 营养组合物的应用、食品

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
JPH08266255A (ja) 1995-03-30 1996-10-15 Taiyo Kagaku Co Ltd 学習能力向上組成物
KR20000035798A (ko) * 1996-08-30 2000-06-26 뷜르 로망 엘. 페닐케톤뇨증 환자용 영양 처방식
AU712430B2 (en) * 1996-10-01 1999-11-04 Massey University Process for isolating high purity glycomacropeptide from dairy products
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
FR2803489B1 (fr) * 2000-01-10 2005-02-11 Lu Utilisation d'un produit cerealier pour ameliorer les performances cognitives et le bien-etre mental chez l'homme et en particulier chez l'enfant et l'adolescent
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
CA2530170A1 (en) 2003-06-24 2005-01-06 University Of Kansas Medical Center Infant formula
WO2005037248A1 (en) * 2003-10-16 2005-04-28 Milcin Therapeutics Llc Glycoprotein and/or glycomacropeptide containing preparations for medical uses

Also Published As

Publication number Publication date
HK1222301A1 (zh) 2017-06-30
CA2606515C (en) 2014-06-03
TWI400082B (zh) 2013-07-01
CN101287486A (zh) 2008-10-15
RU2396975C2 (ru) 2010-08-20
WO2006118719A2 (en) 2006-11-09
US20060247153A1 (en) 2006-11-02
ES2576255T3 (es) 2016-07-06
KR20080003374A (ko) 2008-01-07
KR100988156B1 (ko) 2010-10-18
TW200716158A (en) 2007-05-01
RU2007139808A (ru) 2009-06-10
WO2006118719A3 (en) 2007-03-29
CA2606515A1 (en) 2006-11-09
EP1874336A2 (en) 2008-01-09
EP1874336B1 (en) 2016-04-27
CN105394776A (zh) 2016-03-16
BRPI0609916A2 (pt) 2010-05-11
MY162096A (en) 2017-05-31
NO20075077L (no) 2007-11-20
MX2007013270A (es) 2008-02-11

Similar Documents

Publication Publication Date Title
EP1945322A4 (en) SYSTEMS AND METHODS FOR MANAGING AN EXERCISE PROGRAM
IL226577B (en) Automatic detection of sleep and wakefulness states
DK2258219T3 (da) Næring med lipider og ufordøjelige saccharider
IL184565A0 (en) Conjugates of a polypeptide and an oligosaccharide
EP2046362A4 (en) FORMULATION COMPRISING LACTOSERIC PROTEIN AND HYDROLYSATS FOR PROMOTING MUSCLE RECOVERY
GB2424807B (en) Facilitating and authenticating transactions
ZA200800863B (en) Methods for determining the effect of a treatment on the cross-B structure content of a protein; selection of treatments and uses thereof
EP1751179A4 (en) PEPTIDES DERIVED FROM THE CASEIN AND THEIR THERAPEUTIC USES
EP1903936A4 (en) THERAPEUTIC OBSERVANCE SYSTEM AND ASSOCIATED METHODS
IL183800A0 (en) System and method for enhanced error detection in memory peripherals
WO2006118719A3 (en) Method of improving learning and memory in mammals
PT1711070E (pt) Composição nutricional para melhorar o estado da pele e prevenir doenças de pele
IL193700A0 (en) Medicaments and proteins
GB0707667D0 (en) A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
DK3401327T3 (da) Genprodukter med forskellig ekspression i tumorer og anvendelser deraf
IL185729A0 (en) Crystallization inhibitor and its use in gelatin capsules
ZA200804095B (en) Nucleic acids and proteins associated with galactomannan synthesis in coffee
EP1838525A4 (en) SOFT OBJECTS AND PROCEDURES
TWI292827B (en) Probe card and method of manufacturing the same
EP1783613A4 (en) INFORMATION GENERATION DEVICE AND INFORMATION GENERATION PROGRAM
GB0505544D0 (en) A token and related methods
EP1734983A4 (en) MODIFIED ANNEXINE PROTEINS AND METHODS FOR PREVENTING THROMBOSIS
EP1937294A4 (en) GLYCOLIC AND GLYCOSYLATED THERAPEUTIC PROTEINS DERIVED FROM POULTRY
GB2411019B (en) Data accesses in data processing
PL378597A1 (pl) Sposób i układ do nabiałczania pasz